Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

BROKER RATINGS SUMMARY: Goldman And HSBC Negative On Anglo American

Wed, 25th Nov 2015 09:34

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
GOLDMAN CUTS ANGLO AMERICAN PRICE TARGET TO 430 (450) PENCE - 'SELL'
----------
TRADERS: HSBC CUTS ANGLO AMERICAN TO 'REDUCE' ('HOLD')
----------
UBS RAISES COMPASS GROUP PRICE TARGET TO 1,160 (1,155) PENCE - 'NEUTRAL'
----------
UBS CUTS ASTRAZENECA PRICE TARGET TO 5000 (5500) PENCE - 'BUY'
----------
JPMORGAN RAISES INTERTEK PRICE TARGET TO 2874 (2823) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS INTERTEK PRICE TARGET TO 2,780 (2,820) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS PRUDENTIAL PRICE TARGET TO 1900 (1951) PENCE - 'BUY'
----------
TRADERS: HSBC INITIATES MERLIN ENTERTAINMENTS WITH 'BUY' - TARGET 470 PENCE
----------
TRADERS: HSBC INITIATES WHITBREAD WITH 'BUY' - TARGET 5,400 PENCE
----------
TRADERS: HSBC INITIATES INTERCONTINENTAL HOTELS WITH 'HOLD' - TARGET 2,600 P
----------
GOLDMAN CUTS TRAVIS PERKINS PRICE TARGET TO 2,650 (2,787) PENCE - 'BUY'
----------
GOLDMAN RAISES BABCOCK INTERNATIONAL PRICE TARGET TO 1,302 (1,291)P - 'BUY'
----------
SOCGEN CUTS KINGFISHER PRICE TARGET TO 333 (345) PENCE - 'SELL'
----------
S&P CAPITAL IQ RAISES KINGFISHER TO 'HOLD' ('SELL') - TARGET 360 (330) PENCE
----------
FTSE 250
----------
UBS RAISES PARAGON GROUP PRICE TARGET TO 513 (490) PENCE - 'BUY'
----------
BARCLAYS CUTS PARAGON GROUP PRICE TARGET TO 475 (500) PENCE - 'OVERWEIGHT'
----------
TRADERS: NUMIS RAISES PARAGON GROUP TO 'HOLD' ('REDUCE')
----------
PANMURE RAISES RPC GROUP PRICE TARGET TO 840 (828) PENCE - 'BUY'
----------
TRADERS: INVESTEC RESUMES LADBROKES WITH 'BUY' - TARGET 127 PENCE
----------
SHORE CAPITAL RAISES THOMAS COOK TO 'BUY' ('HOLD')
----------
HSBC INITIATES THOMAS COOK WITH 'HOLD' - TARGET 100 PENCE
----------
HSBC RESUMES NMC HEALTH WITH 'BUY' - TARGET 950 PENCE
----------
LIBERUM RAISES MITIE GROUP PRICE TARGET TO 300 (286) PENCE - 'HOLD'
----------
TRADERS: NUMIS CUTS MITIE GROUP TO 'SELL' ('REDUCE')
----------
LIBERUM RAISES SHAFTESBURY PRICE TARGET TO 1,040 (930) PENCE - 'BUY'
----------
EXANE BNP RAISES SHAFTESBURY PRICE TARGET TO 950 (910) PENCE - 'UNDERPERFORM'
----------
NOMURA CUTS POUNDLAND GROUP PRICE TARGET TO 270 (290) PENCE - 'NEUTRAL'
----------
UBS CUTS HALFORDS GROUP PRICE TARGET TO 380 (480) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS SPECTRIS PRICE TARGET TO 1,830 (1,950) PENCE - 'HOLD'
----------
GOLDMAN CUTS SPECTRIS PRICE TARGET TO 2,200 (2,300) PENCE - 'BUY'
----------
JEFFERIES RAISES HALMA PRICE TARGET TO 925 (875) PENCE - 'BUY'
----------
BARCLAYS CUTS MITCHELLS & BUTLERS PRICE TARGET TO 375 (500) P - 'EQUAL WEIGHT'
----------
S&P CAPITAL IQ RAISES DRAX GROUP TO 'BUY' ('HOLD') - TARGET 290 PENCE
----------
GOLDMAN CUTS PETS AT HOME PRICE TARGET TO 280 (290) PENCE - 'BUY'
----------
HSBC CUTS PETS AT HOME PRICE TARGET TO 340 (360) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES AUTO TRADER PRICE TARGET TO 420 (400) PENCE - 'OVERWEIGHT'
----------
TRADERS: NUMIS RAISES CINEWORLD TO 'ADD' ('HOLD')
----------
MAIN MARKET AND AIM
----------
BARCLAYS CUTS SHANKS GROUP PRICE TARGET TO 95 (100) PENCE - 'EQUAL WEIGHT'
----------
JPMORGAN CUTS DE LA RUE PRICE TARGET TO 500 (570) PENCE - 'NEUTRAL'
----------
Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.